logo

For the Inventor, By the Inventor

Schwenksville, PA, United States of America

Robert S Meissner

This inventor holds 37 USPTO granted patents and 3 published patent applications and 11 EPO patents, primarily in Androgen Receptor Modulators. Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp., Merck Canada Inc.. Active years: 1999-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert S Meissner. Retrieved from https://idiyas.com/inventor/robert-s-meissner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 37 

% Patents Active = 45.9

 

Average Co-Inventor Count = 4.3

ph-index = 10

Forward Citations = 287(Granted Patents)


Location History:

  • Lansdale, PA (US) (1999)
  • Schwenksville, PA (US) (2000 - 2012)
  • Newton, MA (US) (2016 - 2019)

Company Filing History:

goldMedal26 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal11 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal1 out of 40 
 
Merck Canada Inc.
 patents
where one patent can have more than one assignee

Years Active: 1999-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
Androgen Receptor Modulators
Glucocorticoid Receptor Modulators
Integrin Receptor Antagonists
Quinoline Derivatives
Cyanopyridine Derivatives
Tetrahydronaphthyridine
Fibrinogen Receptor Antagonists
Hexahydrocyclopentyl
Fluorinated 4-Azasteroids
D-Homoandrosta Derivatives
Benzazepinone
Negative Allosteric Modulators
37 patents (USPTO):Explore Patents
1. 10239849 - Cyanopyridine derivatives as liver X receptor beta agonists, compositions, and their use (2019-03-26),
2. 10072003 - Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use (2018-09-11),
3. 9663506 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use (2017-05-30),
4. 9636337 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use (2017-05-02),
5. 9278960 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use (2016-03-08),
6. 8338472 - [object Object] (2012-12-25),
7. 8299048 - Hexahydrocyclopentyl[f]indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators (2012-10-30),
8. 8119681 - 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydrocyclopenta [ƒ]indazole-5-YL]ethyl phenyl derivatives as glucocorticoid receptor ligands (2012-02-21),
9. 7763659 - N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators (2010-07-27),
10. 7745657 - D-homoandrosta-17-yl carbamate derivatives as selective glucocorticoid receptor ligands (2010-06-29),
11. 7696217 - 17-acetamido-4-azasteroid derivatives as androgen receptor modulators (2010-04-13),
12. 7629367 - [object Object] (2009-12-08),
13. 7625920 - Fluorinated 4-azasteroid derivatives as androgen receptor modulators (2009-12-01),
14. 7605152 - 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators (2009-10-20),
15. 7482357 - 17-acetamido-4-azasteroid derivatives as androgen receptor modulators (2009-01-27),

Title: Robert S Meissner - Pioneering Inventor from Schwenksville

Introduction: Robert S Meissner is a distinguished inventor hailing from Schwenksville, Pennsylvania. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to various fields through his inventive spirit.

Latest Patents: Robert S Meissner holds several patents in the areas of renewable energy technologies, sustainable agriculture, and advanced materials. His recent patents focus on enhancing energy efficiency and promoting environmental sustainability.

Career Highlights: Throughout his career, Robert S Meissner has been recognized for his groundbreaking inventions that have revolutionized industries. His innovative solutions have garnered acclaim for their practicality and effectiveness in addressing pressing challenges.

Collaborations: Robert S Meissner has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in advancing his ideas from concept to reality, showcasing his ability to work effectively in multidisciplinary teams.

Conclusion: In conclusion, Robert S Meissner stands as a visionary inventor whose creative pursuits have left a lasting impact on various sectors. His dedication to innovation and commitment to making a difference continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…